Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Growth 2025-2031

October 2025 | 86 pages | ID: G27DFA633B96EN
LP Information

Abstracts

The global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market size is predicted to grow from US$ 9434 million in 2025 to US$ 10850 million in 2031; it is expected to grow at a CAGR of 2.4% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of medicine that lower high blood glucose levels and are used in the treatment of type 2 diabetes.

United States market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Dipeptidyl Peptidase-4 (DPP-4) Inhibitors players cover Eli Lilly, Glaxo Smith Kline, Boehringer, Bristol-Myers Squibb, Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Forecast? looks at past sales and reviews total world Dipeptidyl Peptidase-4 (DPP-4) Inhibitors sales in 2024, providing a comprehensive analysis by region and market sector of projected Dipeptidyl Peptidase-4 (DPP-4) Inhibitors sales for 2025 through 2031. With Dipeptidyl Peptidase-4 (DPP-4) Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dipeptidyl Peptidase-4 (DPP-4) Inhibitors industry.

This Insight Report provides a comprehensive analysis of the global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dipeptidyl Peptidase-4 (DPP-4) Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors.

This report presents a comprehensive overview, market shares, and growth opportunities of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Sitagliptin
• Saxagliptin
• Vildagliptin
• Linagliptin

Segmentation by Application:

• Hospital
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Eli Lilly
• Glaxo Smith Kline
• Boehringer
• Bristol-Myers Squibb
• Pfizer
• AstraZeneca
• Sanofi
• Novo Nordisk

Key Questions Addressed in this Report

What is the 10-year outlook for the global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market?
What factors are driving Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market opportunities vary by end market size?
How does Dipeptidyl Peptidase-4 (DPP-4) Inhibitors break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Country/Region, 2020, 2024 & 2031
2.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Type
  2.2.1 Sitagliptin
  2.2.2 Saxagliptin
  2.2.3 Vildagliptin
  2.2.4 Linagliptin
2.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type
  2.3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2020-2025)
  2.3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sale Price by Type (2020-2025)
2.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Others
2.5 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application
  2.5.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sale Market Share by Application (2020-2025)
  2.5.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Breakdown Data by Company
  3.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Annual Sales by Company (2020-2025)
  3.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Company (2020-2025)
3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Annual Revenue by Company (2020-2025)
  3.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Company (2020-2025)
  3.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Company (2020-2025)
3.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sale Price by Company
3.4 Key Manufacturers Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Location Distribution
  3.4.2 Players Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS BY GEOGRAPHIC REGION

4.1 World Historic Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Geographic Region (2020-2025)
  4.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Country/Region (2020-2025)
  4.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Annual Revenue by Country/Region (2020-2025)
4.3 Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth
4.4 APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth
4.5 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth
4.6 Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth

5 AMERICAS

5.1 Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country
  5.1.1 Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2020-2025)
  5.1.2 Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2020-2025)
5.2 Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2020-2025)
5.3 Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region
  6.1.1 APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2020-2025)
  6.1.2 APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2020-2025)
6.2 APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2020-2025)
6.3 APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Country
  7.1.1 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2020-2025)
  7.1.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2020-2025)
7.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2020-2025)
7.3 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Country
  8.1.1 Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2020-2025)
8.2 Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2020-2025)
8.3 Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
10.3 Manufacturing Process Analysis of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
10.4 Industry Chain Structure of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Distributors
11.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Customer

12 WORLD FORECAST REVIEW FOR DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS BY GEOGRAPHIC REGION

12.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size Forecast by Region
  12.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Forecast by Region (2026-2031)
  12.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Forecast by Type (2026-2031)
12.7 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Eli Lilly
  13.1.1 Eli Lilly Company Information
  13.1.2 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolios and Specifications
  13.1.3 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Eli Lilly Main Business Overview
  13.1.5 Eli Lilly Latest Developments
13.2 Glaxo Smith Kline
  13.2.1 Glaxo Smith Kline Company Information
  13.2.2 Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolios and Specifications
  13.2.3 Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Glaxo Smith Kline Main Business Overview
  13.2.5 Glaxo Smith Kline Latest Developments
13.3 Boehringer
  13.3.1 Boehringer Company Information
  13.3.2 Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolios and Specifications
  13.3.3 Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Boehringer Main Business Overview
  13.3.5 Boehringer Latest Developments
13.4 Bristol-Myers Squibb
  13.4.1 Bristol-Myers Squibb Company Information
  13.4.2 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolios and Specifications
  13.4.3 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Bristol-Myers Squibb Main Business Overview
  13.4.5 Bristol-Myers Squibb Latest Developments
13.5 Pfizer
  13.5.1 Pfizer Company Information
  13.5.2 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolios and Specifications
  13.5.3 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Pfizer Main Business Overview
  13.5.5 Pfizer Latest Developments
13.6 AstraZeneca
  13.6.1 AstraZeneca Company Information
  13.6.2 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolios and Specifications
  13.6.3 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 AstraZeneca Main Business Overview
  13.6.5 AstraZeneca Latest Developments
13.7 Sanofi
  13.7.1 Sanofi Company Information
  13.7.2 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolios and Specifications
  13.7.3 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Sanofi Main Business Overview
  13.7.5 Sanofi Latest Developments
13.8 Novo Nordisk
  13.8.1 Novo Nordisk Company Information
  13.8.2 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolios and Specifications
  13.8.3 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Novo Nordisk Main Business Overview
  13.8.5 Novo Nordisk Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Sitagliptin
Table 4. Major Players of Saxagliptin
Table 5. Major Players of Vildagliptin
Table 6. Major Players of Linagliptin
Table 7. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2020-2025) & (Units)
Table 8. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2020-2025)
Table 9. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2020-2025) & ($ million)
Table 10. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type (2020-2025)
Table 11. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sale by Application (2020-2025) & (Units)
Table 13. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sale Market Share by Application (2020-2025)
Table 14. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2020-2025) & ($ million)
Table 15. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application (2020-2025)
Table 16. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Company (2020-2025) & (Units)
Table 18. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Company (2020-2025)
Table 19. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Company (2020-2025)
Table 21. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Producing Area Distribution and Sales Area
Table 23. Players Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Products Offered
Table 24. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Geographic Region (2020-2025) & (Units)
Table 28. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share Geographic Region (2020-2025)
Table 29. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country/Region (2020-2025) & (Units)
Table 32. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country/Region (2020-2025)
Table 33. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2020-2025) & (Units)
Table 36. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2020-2025)
Table 37. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2020-2025) & (Units)
Table 39. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2020-2025) & (Units)
Table 40. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2020-2025) & (Units)
Table 41. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2020-2025)
Table 42. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2020-2025) & (Units)
Table 44. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2020-2025) & (Units)
Table 45. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2020-2025) & (Units)
Table 46. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2020-2025) & (Units)
Table 48. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2020-2025) & (Units)
Table 49. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2020-2025) & (Units)
Table 50. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2020-2025) & (Units)
Table 52. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2020-2025) & (Units)
Table 53. Key Market Drivers & Growth Opportunities of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
Table 54. Key Market Challenges & Risks of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
Table 55. Key Industry Trends of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
Table 56. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Distributors List
Table 59. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Customer List
Table 60. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Region (2026-2031) & (Units)
Table 61. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Country (2026-2031) & (Units)
Table 63. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Region (2026-2031) & (Units)
Table 65. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Country (2026-2031) & (Units)
Table 67. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Country (2026-2031) & (Units)
Table 69. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Type (2026-2031) & (Units)
Table 71. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Application (2026-2031) & (Units)
Table 73. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Eli Lilly Basic Information, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 75. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolios and Specifications
Table 76. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Eli Lilly Main Business
Table 78. Eli Lilly Latest Developments
Table 79. Glaxo Smith Kline Basic Information, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 80. Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolios and Specifications
Table 81. Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Glaxo Smith Kline Main Business
Table 83. Glaxo Smith Kline Latest Developments
Table 84. Boehringer Basic Information, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 85. Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolios and Specifications
Table 86. Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Boehringer Main Business
Table 88. Boehringer Latest Developments
Table 89. Bristol-Myers Squibb Basic Information, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 90. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolios and Specifications
Table 91. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Bristol-Myers Squibb Main Business
Table 93. Bristol-Myers Squibb Latest Developments
Table 94. Pfizer Basic Information, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolios and Specifications
Table 96. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. AstraZeneca Basic Information, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 100. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolios and Specifications
Table 101. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. AstraZeneca Main Business
Table 103. AstraZeneca Latest Developments
Table 104. Sanofi Basic Information, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 105. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolios and Specifications
Table 106. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Sanofi Main Business
Table 108. Sanofi Latest Developments
Table 109. Novo Nordisk Basic Information, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 110. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolios and Specifications
Table 111. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Novo Nordisk Main Business
Table 113. Novo Nordisk Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
Figure 2. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate 2020-2031 (Units)
Figure 7. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country/Region (2024)
Figure 10. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Sitagliptin
Figure 12. Product Picture of Saxagliptin
Figure 13. Product Picture of Vildagliptin
Figure 14. Product Picture of Linagliptin
Figure 15. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type in 2025
Figure 16. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type (2020-2025)
Figure 17. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumed in Hospital
Figure 18. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market: Hospital (2020-2025) & (Units)
Figure 19. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumed in Clinic
Figure 20. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market: Clinic (2020-2025) & (Units)
Figure 21. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumed in Others
Figure 22. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market: Others (2020-2025) & (Units)
Figure 23. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sale Market Share by Application (2024)
Figure 24. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application in 2025
Figure 25. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Company in 2025 (Units)
Figure 26. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Company in 2025
Figure 27. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Company in 2025 ($ millions)
Figure 28. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Company in 2025
Figure 29. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales 2020-2025 (Units)
Figure 32. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue 2020-2025 ($ millions)
Figure 33. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales 2020-2025 (Units)
Figure 34. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue 2020-2025 ($ millions)
Figure 35. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales 2020-2025 (Units)
Figure 36. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales 2020-2025 (Units)
Figure 38. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue 2020-2025 ($ millions)
Figure 39. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country in 2025
Figure 40. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2020-2025)
Figure 41. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2020-2025)
Figure 42. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2020-2025)
Figure 43. United States Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region in 2025
Figure 48. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region (2020-2025)
Figure 49. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2020-2025)
Figure 50. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2020-2025)
Figure 51. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 55. India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country in 2025
Figure 59. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2020-2025)
Figure 60. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2020-2025)
Figure 61. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2020-2025)
Figure 62. Germany Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 63. France Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2020-2025)
Figure 70. Egypt Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in 2025
Figure 76. Manufacturing Process Analysis of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
Figure 77. Industry Chain Structure of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
Figure 78. Channels of Distribution
Figure 79. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Forecast by Region (2026-2031)
Figure 80. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share Forecast by Application (2026-2031)